Analyst firms · Barclays · MDT

Barclays MDT price target and rating history

Medtronic plc. (MDT) · Health Care

Barclays rates Medtronic plc. (MDT) Equal Weight with a $95 price target, as of its latest action on Oct 7, 2026. It has published 3 rating actions on MDT since October 2022, including 0 upgrades and 0 downgrades. Across 7 firms with a MDT price target in the last 12 months, the median target is $100. Barclays's $95 is 5% below that.

Current rating

Equal Weight

Price target

$95

Median target, all firms

$100

Actions on MDT

3

Barclays price target on MDT

Every Barclays rating on MDT

• Oct 7, 2026
  InitiateBarclays starts coverage at Equal Weight, price target $95
• Feb 13, 2026
  ResumeBarclays resumes coverage at Overweight, price target $116
• Oct 18, 2022
  InitiateBarclays starts coverage at Equal Weight, price target $90

How other firms rate MDT

Each firm's latest rating and stated target in the last 12 months.

Questions about Barclays and MDT

What is Barclays's price target for MDT?

Barclays's latest stated price target for Medtronic plc. (MDT) is $95, from its action on Oct 7, 2026.

What is Barclays's rating on MDT?

Barclays rates MDT Equal Weight, a neutral rating, as of Oct 7, 2026.

When did Barclays last change its view on MDT?

On Oct 7, 2026, Barclays starts coverage at Equal Weight, price target $95.

How does Barclays's MDT target compare with other analysts?

Across 7 firms with a MDT price target in the last 12 months, the median target is $100. Barclays's $95 is 5% below that.

More MDT rating histories

• Needham7
• UBS4
• BTIG3
• Goldman Sachs4
• Citigroup6
• Wells Fargo6
• RBC Capital Markets3
• Oppenheimer4
• Morgan Stanley4
• Raymond James3
• Truist Securities3
• Credit Suisse3

All Barclays ratingsMDT news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.